Skip to Content


In the US, Lucinactant (lucinactant systemic) is a member of the drug class lung surfactants and is used to treat Respiratory Distress Syndrome.

US matches:



CAS registry number (Chemical Abstracts Service)


Therapeutic Categories

Pulmonary surfactant

Treatment of neonatal respiratory distress syndrome

Chemical Name

A surfactant formulation containing a mixture of synthetic phospholipids, fatty acid, and synthetic peptide.Lucinactant is comprised of sinapultide, colfosceril palmitate (dipalmitoylphosphatidylcholine [DPPC]), palmitoyloleaylphosphatidyl glycerol, sodiu (USAN)

Foreign Names

  • Lucinactant (German)
  • Lucinactant (French)

Generic Names

  • Lucinactant (OS: USAN)
  • API 02 (IS)
  • ATI 02 (IS)
  • KLâ‚„-surfactant (IS)

Brand Name


ISInofficial Synonym
OSOfficial Synonym
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.